Prevalence of detrusor overactivity among patients with symptoms of overactive bladder: a retrospective cohort study. Reply.

摘要

Dear Editor, We are grateful to Dokmeci and ￡etinkaya for the comments regarding our retrospective study [1]. Whereas we certainly accept that flaws exist, we would like to address a few of the comments. The first is in reference to our exclusion criteria, about which Dokmeci and Cetinkaya stated that patients taking medications that can affect the bladder should have been excluded. Our rationale for including patients on various medications was to see whether there was a relationship between certain drugs and the presence of detrusor overac-tivity (DO). As reported in our article, there were few differences between groups. This would suggest that although these medications may be contributing to symptoms of overactive bladder (OAB), there was no relationship with DO, with the exception of antihypertensive medications. The relationship between these medications and OAB was elaborated upon in the Discussion section and is in agreement with findings by Kupelian et al.